Vaccinex, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Vaccinex, Inc. (VCNX) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of -$2.49 million as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2025-04-15
- 2024-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$2.49M.
- 2024-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$1.32M.
- 2024-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$2.86M.
- 2024-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.65M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2024-12-31 | -$2.49M 10-K · filed 2025-04-15 | |
| 2024-09-30 | -$1.32M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$2.86M 10-Q · filed 2024-11-14 | |
| 2024-03-31 | $2.65M 10-Q · filed 2024-11-14 | |
| 2023-12-31 | -$2.31M 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$3.87M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$423.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $2.40M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $5.19M 10-K · filed 2025-04-15 | |
| 2022-09-30 | $6.32M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $10.94M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $16.19M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $7.41M 10-K/A · filed 2024-04-25 | |
| 2021-09-30 | $11.89M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $16.94M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $22.78M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | -$2.61M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $3.77M 10-Q · filed 2021-11-08 | $3.76M 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$5.58M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | -$1.74M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | -$2.27M 10-K · filed 2022-03-31 | |
| 2019-09-30 | $3.91M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | -$2.38M 10-Q · filed 2020-11-13 | |
| 2019-03-31 | $6.33M 10-Q · filed 2020-11-13 | |
| 2018-12-31 | $15.34M 10-K · filed 2021-03-31 | |
| 2018-09-30 | $23.75M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$115.87M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | -$113.32M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | -$113.49M 10-K · filed 2020-03-09 | |
| 2017-09-30 | -$122.93M 10-Q · filed 2018-11-13 | |
| 2016-12-31 | -$107.06M 10-K · filed 2019-03-13 |